Q&A: Improving Obesity Care Through a Machine Learning Framework
It is imperative that physicians talk to their patients about obesity, make shared treatment decisions, and get patients to the right provider.
Read More
Author: Teresa Sellinger
Q&A: Chemoradiation With Radiotherapy Improves NSCLC Outcomes
“This technology gives us the ability to be more precise and personalized to each patient,” says Percy Lee, MD.
Read More
Comorbidity Clusters Help Predict COPD Hospitalization & Mortality
Objective assessment of comorbidities shows potential to improve prognostication and deploy interventions to reduce modifiable risk.
Read More
Medication Programs Boost Patient Outcomes & Adherence by 20%
According to Samuel K. Peasah, PhD, MBA, RPh, “almost half of patients do not take their medications for several reasons, including forgetfulness or cost.”
Read More
AI Learning Program Improves Tumor Board Recommendation Concordance to Nearly 70%
“Precision medicine is rapidly advancing, and keeping up with the deluge of discoveries requires new ways of processing information,” Dr. Gruber advises.
Read More
Overcuffing & Undercuffing: Effects of Size on the Accuracy of Blood Pressure Readings
Using a one-size-fits-all blood pressure cuff for patients with varying arm sizes can result in significantly inaccurate BP readings.
Read More
Making the Case for Portable MRI in Assessing MS
Study results support the use of portable MRI in creating quality imaging for use in assessing patients with MS.
Read More
PROFILE Trial: Top-Down Treatment Strategy Benefits Patients With Early Crohn’s Disease
A top-down treatment strategy resulted in improved outcomes compared with an accelerated step-down treatment strategy in patients with newly diagnosed Crohn’s disease.
Read More
Promising Data for JAK Inhibitors in Crohn’s Disease
Ritlecitinib and brepocitinib were associated with improved efficacy outcomes compared with placebo in patients with moderate to severe Crohn’s disease.
Read More
Novel Agent VTX002 Shows Promise for Patients With UC in Phase 2 Study
Phase 2 trial associates ritlecitinib and brepocitinib with improved outcomes compared with placebo in patients with moderate to severe ulcerative colitis.
Read More
Risankizumab Displays Efficacy for Patients With UC
Results from a phase 2 study associate VTX002 with increased clinical, endoscopic, and histologic remission rates for patients with moderately to severely active ulcerative colitis.
Read More
Disparities in Access to Neurological Care for MS
Study findings underscore the existence of disparities in geographic access to neurologic care for MS.
Read More
Functionally Distinct Mechanisms Implicated in MS Risk
A recent study led by Philip De Jager, MD, PhD, marked a significant milestone in understanding the clinical heterogeneity of MS outcomes.
Read More
Addressing Spiritual Questions in the Exam Room
Although trained to avoid discussing religion, physicians can engage with patients who initiate these conversations. Here’s how to best handle such situations.
Read More
Is AI Documentation in Healthcare a Blessing or Just the Next Gear in the Treadmill?
What will your workday look and feel like when AI eliminates your need to document, answer messages, or deal with your inbox?
Read More
Addressing Insomnia & Mental Health in Crohn’s Disease
Patients with inflammatory bowel diseases often experience insomnia and various mental health conditions that healthcare providers should monitor.
Read More
Healthcare AI: Physician Replacement Tech Dream in Plain Sight
Is CarePod the future of healthcare in the US? Investors seem excited by the prospect, but questions linger about its ability to provide proper care.
Read More
Don’t Miss the ACTRIMS Kenneth P. Johnson Memorial Lecture!
The ACTRIMS Forum 2024 Kenneth P. Johnson Memorial Lecture, “Pioneering B-Cell Therapies,” will be given by Anne H. Cross, MD.
Read More
ACTRIMS Young Investigators Present “Emerging Concepts in MS”
ACTRIMS Forum 2024 launches with Session 1: “Emerging Concepts in MS,” composed of presentations by Young Investigators selected from submitted abstracts.
Read More
Spend Time at The Square During ACTRIMS Forum 2024
Take a little time during ACTRIMS Forum 2024 to explore The Square, a dynamic neighborhood offering more than 50 shops and restaurants as well as local events.
Read More